Kobo Biotech (BOM:531541) Total Liabilities: ₹2,097.30 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531541 Kobo Biotech Ltd BOM:531541
13 GF Score
Price ₹8.23
View Full Analysis

What is Kobo Biotech Total Liabilities?

Kobo Biotech BOM:531541 -1.91% 13 Total Liabilities is ₹2,097.30 Mil as of Mar. 2025. GuruFocus rates BOM:531541 with a GF Score™ of 13/100.

Kobo Biotech's Total Liabilities for the quarter that ended in Mar. 2025 was ₹2,097.30 Mil.

Kobo Biotech's quarterly Total Liabilities declined from Mar. 2024 (₹2,043.04 Mil) to Jun. 2024 (₹0.00 Mil) but then increased from Jun. 2024 (₹0.00 Mil) to Mar. 2025 (₹2,097.30 Mil).

Kobo Biotech's annual Total Liabilities increased from Mar. 2023 (₹2,033.12 Mil) to Mar. 2024 (₹2,043.04 Mil) and increased from Mar. 2024 (₹2,043.04 Mil) to Mar. 2025 (₹2,097.30 Mil).

Kobo Biotech Total Liabilities Historical Data

* Premium members only.

The historical data trend for Kobo Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobo Biotech Total Liabilities Chart

Kobo Biotech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,377.90 2,016.13 2,033.12 2,043.04 2,097.30

Kobo Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Mar25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,037.60 0.00 2,043.04 0.00 2,097.30
BOM:531541
13GF Score
Kobo Biotech Ltd BOM:531541
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kobo Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Kobo Biotech's Total Liabilities for the fiscal year that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1732.487+(317.14+47.675
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2,097.30

Total Liabilities=Total Assets (A: Mar. 2025 )-Total Equity (A: Mar. 2025 )
=715.901--1381.401
=2,097.30

Kobo Biotech's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1732.487+(317.14+47.675
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2,097.30

Total Liabilities=Total Assets (Q: Mar. 2025 )-Total Equity (Q: Mar. 2025 )
=715.901--1381.401
=2,097.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹2,097.30 Mil mean?
Kobo Biotech (BOM:531541) has a Total Liabilities of ₹2,097.30 Mil as of Mar. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kobo Biotech and its competitors.
Is Kobo Biotech's Total Liabilities too high?
Kobo Biotech's current Total Liabilities is ₹2,097.30 Mil. Overall, Kobo Biotech has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Kobo Biotech's Total Liabilities compare to ZTS?
Kobo Biotech's Total Liabilities of ₹2,097.30 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kobo Biotech and its competitors. Kobo Biotech's current Total Liabilities is ₹2,097.30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobo Biotech stock overvalued right now?
Kobo Biotech (BOM:531541) has a current Total Liabilities of ₹2,097.30 Mil. The current Total Liabilities is ₹2,097.30 Mil. Kobo Biotech's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Kobo Biotech (BOM:531541), the current Total Liabilities is ₹2,097.30 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kobo Biotech Business Description

Address Saki Vihar Road, Unit 104, HYDE Park, Opposite Ansa Industrial Estate, Andheri (East), Mumbai, MH, IND, 400 072
Kobo Biotech Ltd is a pharmaceutical company. Its business comprises the manufacturing and sale of APIs (Active Pharmaceutical Ingredients) based on fermentation technology and Intermediates to pharmaceutical companies.
13GF Score

Get the complete analysis for BOM:531541

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8.23
Price